Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Differential Induction of Functional IgG Using the Plasmodium falciparum Placental Malaria Vaccine Candidate VAR2CSA

Open access

Abstract

BACKGROUND: In Plasmodium falciparum malaria endemic areas placental malaria (PM) is an important complication of malaria. The recurrence of malaria in primigravidae women irrespective of acquired protection during childhood is caused by the interaction between the parasite-expressed VAR2CSA antigen and chondroitin sulfate A (CSA) in the placental intervillous space and lack of protective antibodies. PM impairs fetal development mainly by excessive inflammation processes. After infections during pregnancy women acquire immunity to PM conferred by antibodies against VAR2CSA. Ideally, a vaccine against PM will induce antibody-mediated immune responses that block the adhesion of infected erythrocytes (IE) in the placenta. PRINCIPAL FINDINGS: We have previously shown that antibodies raised in rat against individual domains of VAR2CSA can block IE binding to CSA. In this study we have immunized mice, rats and rabbits with each individual domain and the full-length protein corresponding to the FCR3 VAR2CSA variant. We found there is an inherently higher immunogenicity of C-terminal domains compared to N-terminally located domains. This was irrespective of whether antibodies were induced against single domains or the full-length protein. Species-specific antibody responses were also found, these were mainly directed against single domains and not the full-length VAR2CSA protein. CONCLUSIONS/SIGNIFICANCE: Binding inhibitory antibodies appeared to be against conformational B-cell epitopes. Non-binding inhibitory antibodies reacted highly against the C-terminal end of the VAR2CSA molecule especially the highly polymorphic DBL6ε domain. Differential species-specific induction of antibody responses may allow for more direct analysis of functional versus non-functional B-cell epitopes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0017942

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Antibody responses to recombinant proteins in different species of animals. The reactivity of VAR2CSA-specific IgG from mice (A), rats (B) and rabbits (C) immunized with individual domains (DBL1X-DBL6ε) and FV2 is shown as the mean of all animals immunized with a particular protein. Data are fitted to a sigmoid shaped dose response curve showing the different intrinsic antigenicity of the individual DBL-domains and FV2. For statistical analysis see Table S2.
Figure 1 Antibody responses to recombinant proteins in different species of animals. The reactivity of VAR2CSA-specific IgG from mice (A), rats (B) and rabbits (C) immunized with individual domains (DBL1X-DBL6ε) and FV2 is shown as the mean of all animals immunized with a particular protein. Data are fitted to a sigmoid shaped dose response curve showing the different intrinsic antigenicity of the individual DBL-domains and FV2. For statistical analysis see Table S2.CC BY · PubMed Central
Figure 2 Antibody reactivity against native and surface expressed VAR2CSA. Serum from mice (A), rats (B) and rabbits (C) immunized with individual domains (DBL1X-DBL6ε) and FV2 was tested using FACS for reactivity against native VAR2CSA expressed on the surface of IE. Antibody surface reactivity is shown for FV2 and DBL1X-DBL6ε groups of animals as the median fluorescence intensity. Negative controls are serum from animals immunized with DBL3γVAR1 and a blank sample without serum.
Figure 2 Antibody reactivity against native and surface expressed VAR2CSA. Serum from mice (A), rats (B) and rabbits (C) immunized with individual domains (DBL1X-DBL6ε) and FV2 was tested using FACS for reactivity against native VAR2CSA expressed on the surface of IE. Antibody surface reactivity is shown for FV2 and DBL1X-DBL6ε groups of animals as the median fluorescence intensity. Negative controls are serum from animals immunized with DBL3γVAR1 and a blank sample without serum.CC BY · PubMed Central
Figure 3 Comparison of surface reactivity and inhibition of FCR3-IE adhesion to CSPG. (A) Anti-VAR2CSA serum from rats and rabbits raised against DBL1X-DBL6ε and FV2 were tested using FCR3-IE for the ability of serum used in a 1∶10 dilution to inhibit binding to CSA in a 96-well plate assay. The data shown are the ratios of binding compared to the negative DBL3γVAR1 control ((Binding [test sample])/(Binding [negative control])). (B) IgG was purified from selected inhibitory and non-inhibitory sera and tested for reactivity in FACS at 1 mg/ml. DBL3γVAR1 was used as negative control. (C) Inhibition of binding to CSA using purified IgG at 0.5 mg/ml in the Petri dish assay. Error bars represents standard deviations.
Figure 3 Comparison of surface reactivity and inhibition of FCR3-IE adhesion to CSPG. (A) Anti-VAR2CSA serum from rats and rabbits raised against DBL1X-DBL6ε and FV2 were tested using FCR3-IE for the ability of serum used in a 1∶10 dilution to inhibit binding to CSA in a 96-well plate assay. The data shown are the ratios of binding compared to the negative DBL3γVAR1 control ((Binding [test sample])/(Binding [negative control])). (B) IgG was purified from selected inhibitory and non-inhibitory sera and tested for reactivity in FACS at 1 mg/ml. DBL3γVAR1 was used as negative control. (C) Inhibition of binding to CSA using purified IgG at 0.5 mg/ml in the Petri dish assay. Error bars represents standard deviations.CC BY · PubMed Central
Figure 4 Reactivity of FV2-specific antibodies to single recombinant DBL-domains. The data shown are pools of serum from rats and rabbits immunized with FV2 tested in ELISA for reactivity towards single recombinant domains of VAR2CSA and FV2. Error bars represent standard deviations of triplicate measurements.
Figure 4 Reactivity of FV2-specific antibodies to single recombinant DBL-domains. The data shown are pools of serum from rats and rabbits immunized with FV2 tested in ELISA for reactivity towards single recombinant domains of VAR2CSA and FV2. Error bars represent standard deviations of triplicate measurements.CC BY · PubMed Central
Figure 5 Antibody reactivity against DBL4ε epitopes measured by peptide analysis. (A) Mean IgG reactivity against DBL4ε peptides in individual serum samples from rats (n = 10) (Dash dot line) and rabbits (n = 4) (Solid line) immunized with DBL4ε recombinant protein is measured using ELISA. Black bars represent epitopes mapped on the structure model of DBL4ε. (B) The structure model of the DBL4ε domain. The major peak (p3–p6) is yellow and the minor peak (p33–p38) is red.
Figure 5 Antibody reactivity against DBL4ε epitopes measured by peptide analysis. (A) Mean IgG reactivity against DBL4ε peptides in individual serum samples from rats (n = 10) (Dash dot line) and rabbits (n = 4) (Solid line) immunized with DBL4ε recombinant protein is measured using ELISA. Black bars represent epitopes mapped on the structure model of DBL4ε. (B) The structure model of the DBL4ε domain. The major peak (p3–p6) is yellow and the minor peak (p33–p38) is red.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. AV Oleinikov, 2008, VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein., J Infect Dis, 197, 1119, 10.1086/529526 · DOI

Cited by

See all 18

Metadata

Authors
Pinto, V. V., Ditlev, S. B., Jensen, K. E., Resende, M., Dahlbäck, M., Andersen, G., Andersen, P., Theander, T. G., Salanti, A., & Nielsen, M. A.
Affiliations
University of Copenhagen (DK)
Corresponding author
Nielsen, Morten A.
Venue
PLoS ONE
Published
2011-03-25
Volume
6
Issue
3
Pages
e17942
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1976268367
Cited by
18
References
43
Citations by year
2024: 1 · 2023: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
2.51
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Bill and Melinda Gates Foundation (47029)
  • European Commission (201222)
  • Novo Nordisk
  • Novo Nordisk Fonden
  • FP7 Health
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
Keywords
placental malaria, VAR2CSA, Plasmodium falciparum, chondroitin sulfate A, C-terminal domain, B-cell epitopes, inhibitory antibodies, erythrocyte adhesion, immunogenicity
MeSH terms
Animals, Antibodies, Protozoan, Antibody Formation, Epitopes, Antigens, Protozoan, Enzyme-Linked Immunosorbent Assay, Erythrocytes, Female, Humans, Immunoglobulin G, Placenta, Plasmodium falciparum, Pregnancy, Rabbits, Recombinant Proteins, Species Specificity, Malaria, Falciparum, Protein Structure, Tertiary, Malaria Vaccines, Protein Array Analysis, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential Induction of Functional IgG Using the Plasmodium falciparum Placental Malaria Vaccine Candidate VAR2CSA. https://app.cochat.ai/papers/10.1371/journal.pone.0017942
The paper
Pinto, V. V., Ditlev, S. B., Jensen, K. E., Resende, M., Dahlbäck, M., Andersen, G., Andersen, P., Theander, T. G., Salanti, A., & Nielsen, M. A. (2011). Differential Induction of Functional IgG Using the Plasmodium falciparum Placental Malaria Vaccine Candidate VAR2CSA. PLoS ONE. https://doi.org/10.1371/journal.pone.0017942

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.